Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A12 | P48065 | 3/20 | 0.45 |
| ▸ | SLC6A11 | P48066 | 3/20 | 0.45 |
| ▸ | SLC6A13 | Q9NSD5 | 3/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 10/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17934358 | 1.00 | SLC6A12 (0.45) | SLC6A12SLC6A11SLC6A13KDM4EALDH1A1 | |
| SCHEMBL9887148 | 1.00 | SLC6A12 (0.45) | SLC6A12SLC6A11SLC6A13KDM4EALDH1A1 | |
| SCHEMBL1787909 | 1.00 | SLC6A12 (0.45) | SLC6A12SLC6A11SLC6A13KDM4EALDH1A1 | |
| SCHEMBL29936790 | 1.00 | SLC6A12 (0.45) | SLC6A12SLC6A11SLC6A13KDM4EALDH1A1 | |
| SCHEMBL560786 | 1.00 | SLC6A12 (0.45) | SLC6A12SLC6A11SLC6A13KDM4EALDH1A1 | |
| SCHEMBL23694121 | 1.00 | SLC6A12 (0.45) | SLC6A12SLC6A11SLC6A13KDM4EALDH1A1 | |
| SCHEMBL17331216 | 1.00 | SLC6A12 (0.45) | SLC6A12SLC6A11SLC6A13KDM4EALDH1A1 | |
| SCHEMBL2380644 | 0.93 | KDM4E (0.40) | SLC6A12SLC6A11SLC6A13KDM4EALDH1A1 | |
| Dimethyl Succinate SCHEMBL29206226 | 0.85 | TSHR (0.39) | SLC6A12SLC6A11SLC6A13KDM4EALDH1A1 | |
| SCHEMBL8464466 | 0.85 | KDM4E (0.42) | KDM4EALDH1A1TDP1LMNAPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 636 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12622070-B2 | Encapsulant film based on functionalized polyolefins | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2026-05-05 | — | — | US | claimed |
| EP-4725976-A1 | POLYMERIC CYCLOALIPHATIC EPOXIDES | ARKEMA FRANCE (FR) | 2026-04-15 | — | — | EP | claimed |
| US-20250374687-A1 | ENCAPSULANT FILM BASED ON FUNCTIONALIZED POLYOLEFINS | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2025-12-04 | — | — | US | claimed |
| EP-4337738-B1 | HOT MELT ADHESIVE COMPRISING FUNCTIONALIZED POLYOLEFINS | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2025-11-26 | — | — | EP | claimed |
| US-12472267-B2 | Compositions containing nucleic acid nanoparticles with modular functionality | Sixfold Bioscience Ltd. (GB) | 2025-11-18 | — | — | US | claimed |
| EP-4477690-B1 | ENCAPSULANT FILM BASED ON FUNCTIONALIZED POLYOLEFINS | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2025-08-13 | — | — | EP | claimed |
| US-12384946-B2 | Hot melt adhesive comprising functionalized polyolefins | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2025-08-12 | — | — | US | claimed |
| WO-2025122010-A1 | A METHOD FOR PURIFYING A MODIFIED GELATIN | SENTRYX B.V. (NL) | 2025-06-12 | — | — | WO | claimed |
| CN-119384451-A | Encapsulation films based on functionalized polyolefins | SABIC环球技术有限责任公司 | 2025-01-28 | — | — | CN | claimed |
| US-20250019469-A1 | SOLUTION PROCESS FOR PRODUCTION OF FUNCTIONALIZED POLYOLEFINS | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2025-01-16 | — | — | US | claimed |
| US-6995226-B2 | Open-ring copolymer, hydrogenated open-ring copolymer, process for production of both, and compositions | ZEON CORPORATION (JP) | 2006-02-07 | — | — | US | claimed |
| CN-1210317-C | Addition polymers of polycycloolefines containing functional substituents | SUMITOMO BAKELITE CO (JP) | 2005-07-13 | — | — | CN | claimed |
| US-20040152843-A1 | Open-ring copolymer, hydrogenated open-ring copolymer, process for production of both, and compositions | ZEON CORPORATION (JP) | 2004-08-05 | — | — | US | claimed |
| EP-1408064-A1 | OPEN-RING COPOLYMER, HYDROGENATED OPEN-RING COPOLYMER, PROCESSES FOR PRODUCTION OF BOTH, AND COMPOSITIONS | Zeon Corporation (JP) | 2004-04-14 | — | — | EP | claimed |
| EP-0828764-B1 | ADDITION POLYMERS OF POLYCYCLOOLEFINS CONTAINING FUNCTIONAL SUBSTITUENTS | GOODRICH CO B F (US) | 2000-09-06 | — | — | EP | claimed |
| US-6111041-A | CONTACTING ACRYLATE AND/OR NORBORNENE MONOMER REACTANT UNDER POLYMERIZATION CONDITIONS AND IN THE PRESENCE OF A SOLVENT WITH A CATALYST SYSTEM CONSISTING ESSENTIALLY OF A PD(II) DIMER COMPONENT | THE PENN STATE RESEARCH FOUNDATION (US) | 2000-08-29 | — | — | US | claimed |
| CN-1190410-A | Addition polymers of polycycloolefines containing functional substituents | GOODRICH CO B F (US) | 1998-08-12 | — | — | CN | claimed |
| EP-0828764-A1 | ADDITION POLYMERS OF POLYCYCLOOLEFINS CONTAINING FUNCTIONAL SUBSTITUENTS | The B.F. Goodrich Company (US) | 1998-03-18 | — | — | EP | claimed |
| WO-1996037526-A1 | ADDITION POLYMERS OF POLYCYCLOOLEFINS CONTAINING FUNCTIONAL SUBSTITUENTS | THE B.F. GOODRICH COMPANY (US) | 1996-11-28 | — | — | WO | claimed |
| EP-0374410-A2 | 2-Azabicyclo[2.2.1]hept-5-ene-2-acetic acid, derivatives thereof and related compounds, process for the preparation of said compounds and the use of said compounds for the manufacture of N-phosphonomethylglycine | AMERICAN CYANAMID COMPANY (US) | 1990-06-27 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12622070-B2 | Encapsulant film based on functionalized polyolefins | EPCAM, CDH1, CD4 | SLC6A12 1005/4885SLC6A11 1703/4885SLC6A13 983/4885 |
| US-12472267-B2 | Compositions containing nucleic acid nanoparticles with modular functionality | NCL, NSUN3, POLN | SLC6A12 4061/4885SLC6A11 4742/4885SLC6A13 4708/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.